RJR-2429 is a drug that acts as an agonist at neural nicotinic acetylcholine receptors, binding to both the α3β4 and the α4β2 subtypes. RJR-2429 is stronger than nicotine but weaker than epibatidine in most assays, and with high affinity for both α3β4 and α4β2 subtypes, as well as the less studied α1βγδ subtype.[1][2][3]
Identifiers | |
---|---|
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
CompTox Dashboard (EPA) |
|
Chemical and physical data | |
Formula | C12H16N2 |
Molar mass | 188.274 g·mol−1 |
3D model (JSmol) |
|
| |
|